IMMUNEONCIA

Serial Number 98513235
Registration 7669086
700

Registration Progress

Application Filed
Apr 22, 2024
Under Examination
Approved for Publication
Dec 10, 2024
Published for Opposition
Dec 10, 2024
Registered
Jan 28, 2025

Trademark Image

IMMUNEONCIA

Basic Information

Serial Number
98513235
Registration Number
7669086
Filing Date
April 22, 2024
Registration Date
January 28, 2025
Published for Opposition
December 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 28, 2025
Registration
Registered
Classes
005

Rights Holder

ImmuneOncia Therapeutics, Inc.

03
Address
Giheung-gu
25, Tapsil-ro 35 beon-gil
Yongin-si, Gyeonggi-do 17084
KR

Ownership History

ImmuneOncia Therapeutics, Inc.

Original Applicant
03
Yongin-si, Gyeonggi-do KR

ImmuneOncia Therapeutics, Inc.

Owner at Publication
03
Yongin-si, Gyeonggi-do KR

ImmuneOncia Therapeutics, Inc.

Original Registrant
03
Yongin-si, Gyeonggi-do KR

Legal Representation

Attorney
Stephanie N. Nikitenko

USPTO Deadlines

Next Deadline
1855 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250128)
Due Date
January 28, 2031
Grace Period Ends
July 28, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Jan 28, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 28, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 13, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 13, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 13, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 13, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 22, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 22, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Anti-cancer preparations; Tumor suppressing agents; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for tumor treatment; Pharmaceutical preparations for treating and preventing immune system diseases; Immune checkpoint inhibitors for use as anti-cancer preparations; Pharmaceuticals being antibodies for medical purposes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations and substances for the treatment of obesity; Pharmaceutical preparations and substances for the treatment of fibrosis; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; Adhesive plasters for medical purposes; Plasters for medical purposes

Classification

International Classes
005